TJX has recovered 2.3% this week to $133.80, but that rebound sits against a backdrop of analyst downgrades, a sharp drawdown in short interest, and options that remain measured rather than excited, a setup where the technicals and the fundamentals are pulling in different directions.
The lending market offers little drama here. Short interest has dropped 15.5% over the past week to just 1.7% of the free float, unwinding the cluster that sat around 21.9 million shares for much of mid-September and settling back toward the low end of the recent range. Borrow costs are similarly relaxed at 0.34%, down more than a quarter on the week, and availability is entirely unconstrained, with well over a billion shares available relative to the roughly 18.5 million currently borrowed. There is no short squeeze tension here, no pressure building in the lending pool, and no evidence that bears are adding to positions. The short score has also drifted lower, from 32.6 in mid-September to 31.1 now, a move that puts short pressure in the 69th percentile of the universe but is trending in the wrong direction for any squeeze thesis. Options confirm the same lack of urgency: the put/call ratio sits at 0.65, fractionally above its 20-day average of 0.63 and well within one standard deviation. Positioning, in sum, looks indifferent rather than charged in either direction.
The Street tells a more conflicted story. Jefferies and Citigroup both downgraded TJX in late August, each cutting from Buy and both lowering price targets sharply. Jefferies moved to Hold with a $145 target; Citi went to Neutral at $154. Those downgrades followed the August earnings print, which sent the stock down nearly 6.7% on the day and a further 9.3% over the following five sessions. Morgan Stanley kept its Overweight rating but cut its target from $181 to $178. UBS bucked the trend, maintaining Buy and actually nudging its target higher to $198. The consensus has landed on Hold, with a mean price target around $169.80, roughly 27% above where the stock closed Tuesday. That gap is large enough to note, but it reflects a heavily skewed distribution: the bulls at UBS and BTIG sit well above $188 while the downgrade camp has anchored around $145 to $155. Valuation multiples have drifted in the right direction this week, with EV/EBITDA adding roughly 0.38 turns over seven days to 16.2x, and the P/E ticking up to 23.7x. On factor scores, dividend quality ranks in the 99th percentile of the universe, but forward earnings momentum scores poorly at 19, consistent with the Street's concern that the near-term earnings growth profile is unexciting even if the business model is durable.
The bull and bear cases reflect genuine uncertainty about whether TJX's August stumble was a one-off or a signal. Bulls point to fiscal 2026 revenue of roughly $60 billion, more than 5,000 stores across the US, Canada, Europe and Australia, and a business model that has historically attracted traffic across income groups when consumers are under pressure. HomeGoods posted 7% comps last quarter, TJX International delivered 7%, and the company ended Q2 with $6 billion of cash. Bears counter that the Q1 beat relied heavily on merchandise margin tailwinds, favourable hedging and expense leverage rather than a structurally faster growth rate, and that any sustained execution slip at Marmaxx, which generates 61% of sales, could unwind those gains quickly. The August print, which showed Marmaxx softer than the company's other banners, has kept that concern alive.
Retail attention around TJX is running elevated by its own standards. The ORTEX alt data layer measures Wikipedia views and ORTEX page-view data and flags a z-score of 2.81 as of September 18, well above the trailing 90-day norm. Neither of the company's two alt data datasets carries a measured lead status against its reported figures, so this signal speaks to investor attention rather than fundamental trajectory. There are no verified operational facts or records in the current period. The cluster of insider sales from June, with CEO Ernie Herrman selling 10,002 shares at $160.68 and CFO John Klinger selling 6,235 shares at $160.77, are the most recent Form 4 filings, and both were straightforward open-market sales, not under a 10b5-1 plan. With net insider activity at zero over the 90 days to mid-September, there is no directional signal from insiders either.
Among close peers, BURL is the week's standout, up 5.1%, while ROST has added just 0.8%. AEO jumped 13.9% and GAP climbed 9.7%, suggesting the broader apparel retail complex caught a bid this week that TJX only partially shared. With the next earnings event scheduled for November 18, the key question over the coming weeks is whether Marmaxx comp momentum has stabilised or whether the September quarter carries the same softness that prompted the post-August analyst repositioning.
See the live data behind this article on ORTEX.
Open TJX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
